Paradigm Biopharmaceutical Ltd's PPS heart failure treatment generates promising data from pre-clinical animal model trial
![Biohaven Announces Preliminary 2Q2021 Net Product Revenue For NURTEC ODT, The First And Only Migraine Medication For Both Acute And Preventive Treatment Biohaven Announces Preliminary 2Q2021 Net Product Revenue For NURTEC ODT, The First And Only Migraine Medication For Both Acute And Preventive Treatment](https://mma.prnewswire.com/media/413973/Biohaven_Pharmaceutical_Holding_Company_Ltd_Logo.jpg?p=facebook)
Biohaven Announces Preliminary 2Q2021 Net Product Revenue For NURTEC ODT, The First And Only Migraine Medication For Both Acute And Preventive Treatment
![Weekly stock relay] Biden's biomanufacturing initiative's impact on Korean biopharma 'limited' < Special < Article - KBR Weekly stock relay] Biden's biomanufacturing initiative's impact on Korean biopharma 'limited' < Special < Article - KBR](https://cdn.koreabiomed.com/news/photo/202209/14649_15319_320.jpg)
Weekly stock relay] Biden's biomanufacturing initiative's impact on Korean biopharma 'limited' < Special < Article - KBR
Ray Pharmaceuticals - BD provides industry-leading needle technologies, refillable syringes, safety and self-injection systems for pharmaceutical and bio-tech companies across the globe. With thousands of medical devices making their way through your
![Shuwen Biotech and Bliss Biopharmaceutical Partner on Companion Diagnostics for Cancer Drugs | Technology Networks Shuwen Biotech and Bliss Biopharmaceutical Partner on Companion Diagnostics for Cancer Drugs | Technology Networks](https://assets.technologynetworks.com/production/dynamic/images/content/304443/shuwen-biotech-and-bliss-biopharmaceutical-partner-on-companion-diagnostics-for-cancer-drugs-304443-270x270.jpg)
Shuwen Biotech and Bliss Biopharmaceutical Partner on Companion Diagnostics for Cancer Drugs | Technology Networks
Ark Biopharmaceutical Announces NMPA Acceptance and Priority Review of New Drug Application for Ziresovir for Treatment of RSV Infection
![Urokinase Market Increasing prevalence of pulmonary embolism is driving growth of Market 2028 | Jiangsu Aidea Pharmaceutical Co Ltd, Jiangxi Haoran Bio-Pharma Co. Ltd, Cadila Healthcare Limited, Wilex AG. | Medgadget Urokinase Market Increasing prevalence of pulmonary embolism is driving growth of Market 2028 | Jiangsu Aidea Pharmaceutical Co Ltd, Jiangxi Haoran Bio-Pharma Co. Ltd, Cadila Healthcare Limited, Wilex AG. | Medgadget](https://www.medgadget.com/wp-content/uploads/2022/02/urokinase-market-370x223.jpg)